SC
BMY icon

Swan Capital’s Bristol-Myers Squibb BMY Stock Holding History

Swan Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2K Sell
168
-10
-6% -$583 ﹤0.01% 201
2025
Q4 		$9.6K Sell
178
-236
-57% -$11.4K ﹤0.01% 176
2025
Q3 		$18.7K Hold
414
– – 0.01% 123
2025
Q2 		$19.2K Hold
414
– – 0.01% 114
2025
Q1 		$25.3K Hold
414
– – 0.01% 87
2024
Q4 		$23.4K Sell
414
-256
-38% -$14.3K 0.01% 92
2024
Q3 		$34.7K Hold
670
– – 0.02% 83
2024
Q2 		$27.8K Buy
+670
New +$30K 0.02% 90

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Swan Capital's BMY Position: Q1 2026 in Review

Swan Capital reduced its Bristol-Myers Squibb (BMY) stake by 5.6% in Q1 2026, selling an estimated $583 and leaving 168 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #201.

Swan Capital first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. The position peaked at $34.7K in Q3 2024. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Swan Capital held 168 shares of Bristol-Myers Squibb worth $10.2K as of Q1 2026.
  • Swan Capital sold 10 Bristol-Myers Squibb shares in Q1 2026, an estimated $583.
  • Bristol-Myers Squibb made up ﹤0.01% of Swan Capital's portfolio in Q1 2026, its #201 holding.
  • Swan Capital first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
  • Swan Capital's Bristol-Myers Squibb position peaked at $34.7K in Q3 2024.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.